July 14, 2022
The European Blood Alliance (EBA), the association of not-for-profit Blood Establishments, welcomes the European Commission’s proposal for a Regulation on standards of quality and safety for substances of human origin intended for human application, published today, 14 July 2022. Twenty years after the current blood directive was adopted, this proposal builds on that landmark legislation which ensured safety and quality of blood products across Europe, reinforcing its most fundamental principles: blood as a key human resource, voluntary non-remunerated donation, and donor protection.
In addition, the EBA is equally pleased that the European Commission listened to blood establishments, and many other stakeholders, who called for a more agile legal framework that is quicker to adapt to the latest scientific evidence and to innovative approaches and products.
Pierre Tiberghien, President of EBA, said:
“This proposal is a very good basis to ensure that European citizens can continue to expect safe and high-quality blood products, while also strengthening patient and donor protection and granting EU’s legal framework a much-needed flexibility to adapt to new scientific evidence and innovation.”
EBA will now analyse the proposal in more detail on the basis of adequacy and safety of blood supply and we call on members of the European Parliament and representatives in the European Council to listen to the views of EBA and blood establishments as they consider any changes to this proposal.
The European Blood Alliance (EBA) is an association of not-for-profit Blood Establishments, with 28 members throughout the European Union, United Kingdom, and EFTA States. Our mission is threefold:
EBA strives towards this mission by assisting our members to improve performance through collaboration, to engage in regulatory affairs to promote best practice and to facilitate information collection and knowledge exchange.
Peter O’Leary, Executive Director; email@example.com